InvestSMART

Chrysos Corporation Limited (ASX:C79)

ALERT: Price-sensitive ASX Announcement for C79
Current share price for C79 : $5.700 -2 (-25.97%)+
Announcement
Release
18 Feb 2026 8:53AM
Price at Release
$7.700
Full Release
download
Summary
Chrysos Corporation Limited reported significant growth in its financial and operational performance for the first half of fiscal year 2026. The company achieved a 49% increase in total revenue year-over-year, reaching $43.3 million, driven by the global adoption of its PhotonAssay technology. The EBITDA grew by 152% to $14.4 million, with the EBITDA margin improving from 20% to 33%, underscoring the company's operational efficiency and economies of scale. Chrysos deployed four new PhotonAssay units and secured eight new lease agreements, expanding its contracted units to 72. The company remains well-funded, with $21.6 million in cash and substantial undrawn debt facilities, supporting its continued global expansion. The strong financial results were bolstered by record sample volumes and increased utilisation of the PhotonAssay technology, which provides faster, safer, and more accurate gold analysis. Chrysos continues to focus on expanding its market presence and enhancing its technological offerings.
Key Points
  • 49% increase in total revenue year-over-year to $43.3 million.
  • EBITDA grew by 152% to $14.4 million with an improved margin of 33%.
  • Four new PhotonAssay units deployed and eight new lease agreements signed.
  • Total contracted units expanded to 72.
  • Strong funding position with $21.6 million in cash and substantial undrawn debt facilities.
  • Record sample volumes and increased utilisation of PhotonAssay technology.
  • Continued focus on global expansion and technological enhancements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.